Keep up to date with every new upload!

Join free & follow CHI Podcasts
IMPACT 2017 | Parker Institute for Cancer Immunotherapy -Tumor Epitope Selection Alliance (TESLA)

IMPACT 2017 | Parker Institute for Cancer Immunotherapy -Tumor Epitope Selection Alliance (TESLA)

Danny Wells speaks to CHI on July 6th, 2017. Dr. Wells will be speaking during Neoantigen-Based Personalized Immunotherapies meeting at ImPACT: Immunotherapy Progress and Clinical Treatments, December 5-7th, 2018 in San Diego, California.

Topics include scaling up personalized therapies, future clinical applications of neoantigens, and new frontiers in cancer immunotherapy.

For more information, please visit http://www.ImpactImmunotherapy.com/Neoantigen-Immunotherapy/

Comments